Related Experiment Videos
Hypertension in dialysis patients
G Bellinghieri1, D Santoro, G Mazzaglia
1Chair and Division of Nephrology, University of Messina, Italy. gbellinghieri@eniware.it
Insights
Hypertension is common in dialysis patients due to multiple factors including fluid overload and hormonal imbalances. Understanding these causes is crucial for managing cardiovascular risks in this population.
Area of Science:
- Nephrology
- Cardiology
- Hypertension Research
Background:
- Hypertension is a significant risk factor for cardiovascular complications in dialysis patients.
- The exact causes of hypertension in dialysis patients are multifactorial and not fully understood.
- Hypervolemia and hormonal disturbances are implicated in dialysis-related hypertension.
Purpose of the Study:
- To explore the complex pathogenesis of hypertension in dialysis patients.
- To investigate the role of various factors, including hormonal profiles and autonomic dysfunction, in dialysis-induced hypertension.
- To analyze the impact of erythropoietin therapy on hypertension incidence in dialysis patients.
Main Methods:
- Review of existing literature on hypertension in dialysis.
- Analysis of hormonal profiles, including renin-angiotensin system, catecholamines, vasopressin, and endothelin.
- Assessment of autonomic dysfunction in hemodialysis patients.
- Examination of data from the First Report on Dialysis and Transplant in Sicily.
Main Results:
- Hypertension is a leading cause of end-stage renal disease (ESRD), accounting for 8% of cases in Sicily.
- The incidence of hypertension as a cause of ESRD increases with age.
- Factors such as hypervolemia, activated renin-angiotensin system, increased catecholamines, vasopressin, endothelin, and potentially decreased nitrous oxide activity contribute to hypertension.
- The role of autonomic dysfunction in blood pressure control in hemodialysis patients requires further clarification.
- Erythropoietin use may be associated with increased hypertension incidence.
Conclusions:
- Hypertension in dialysis patients is a complex condition with multifactorial origins.
- Further research is needed to elucidate the precise mechanisms and the role of autonomic dysfunction.
- Management strategies should address fluid balance, hormonal regulation, and potential iatrogenic factors like erythropoietin therapy.
Abstract:
Hypertension is a major risk for cardiovascular complications in dialysis patients. The pathogenesis of hypertension is multifactorial and is not completely understood. Hypervolemia has always been considered a major pathogenetic factor. In addition, a disturbed hormone profile with an activated renin angiotensin system, increased catecholamine, vasopressin and endothelin, and perhaps decreased nitrous oxide activity seem to play a role in the high incidence of hypertension in dialysis patients. The influence of autonomic dysfunction on blood pressure control in hemodialysis patients is not clear. The frequent use of erythropoietin during the last decade may have contributed to the increased incidence of hypertension in the dialysis population. Data from the First Report on Dialysis and Transplant in Sicily showed that hypertension is the cause of end-stage renal disease in 8% of dialysis patients and that the incidence of hypertension, as a cause of end-stage renal disease, increased with age.